380 related articles for article (PubMed ID: 34071255)
1. Ischemia-Reperfusion Injury in Lung Transplantation.
Chen-Yoshikawa TF
Cells; 2021 May; 10(6):. PubMed ID: 34071255
[TBL] [Abstract][Full Text] [Related]
2. Update on ischemia-reperfusion injury in lung transplantation.
Chen F; Date H
Curr Opin Organ Transplant; 2015 Oct; 20(5):515-20. PubMed ID: 26348570
[TBL] [Abstract][Full Text] [Related]
3. Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.
Wang X; O'Brien ME; Yu J; Xu C; Zhang Q; Lu S; Liang L; An X; McDyer JF; Mallampalli RK
Am J Respir Cell Mol Biol; 2019 Aug; 61(2):244-256. PubMed ID: 30742487
[TBL] [Abstract][Full Text] [Related]
4. Liquid Ventilation Reconditions Isolated Rat Lungs Following Ischemia-Reperfusion Injury.
Becerra D; Linge H; Jeffs S; Roberts S; O J; Ott HC
Tissue Eng Part A; 2022 Nov; 28(21-22):918-928. PubMed ID: 35946070
[TBL] [Abstract][Full Text] [Related]
5. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.
Iske J; Hinze CA; Salman J; Haverich A; Tullius SG; Ius F
Am J Transplant; 2021 Dec; 21(12):3831-3839. PubMed ID: 34355495
[TBL] [Abstract][Full Text] [Related]
6. Infusion of mesenchymal stem cells protects lung transplants from cold ischemia-reperfusion injury in mice.
Tian W; Liu Y; Zhang B; Dai X; Li G; Li X; Zhang Z; Du C; Wang H
Lung; 2015 Feb; 193(1):85-95. PubMed ID: 25344633
[TBL] [Abstract][Full Text] [Related]
7. Plasmin administration during ex vivo lung perfusion ameliorates lung ischemia-reperfusion injury.
Motoyama H; Chen F; Hijiya K; Kondo T; Ohsumi A; Yamada T; Sato M; Aoyama A; Bando T; Date H
J Heart Lung Transplant; 2014 Oct; 33(10):1093-9. PubMed ID: 25043623
[TBL] [Abstract][Full Text] [Related]
8. Bronchodilator Inhalation During Ex Vivo Lung Perfusion Improves Posttransplant Graft Function After Warm Ischemia.
Hijiya K; Chen-Yoshikawa TF; Kondo T; Motoyama H; Ohsumi A; Nakajima D; Sakamoto J; Ohata K; Takahashi M; Tanaka S; Miyamoto E; Aoyama A; Date H
Ann Thorac Surg; 2017 Feb; 103(2):447-453. PubMed ID: 27737734
[TBL] [Abstract][Full Text] [Related]
9. The endothelium: gatekeeper to lung ischemia-reperfusion injury.
Ta HQ; Kuppusamy M; Sonkusare SK; Roeser ME; Laubach VE
Respir Res; 2024 Apr; 25(1):172. PubMed ID: 38637760
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation.
Nakajima D; Watanabe Y; Ohsumi A; Pipkin M; Chen M; Mordant P; Kanou T; Saito T; Lam R; Coutinho R; Caldarone L; Juvet S; Martinu T; Iyer RK; Davies JE; Hwang DM; Waddell TK; Cypel M; Liu M; Keshavjee S
J Heart Lung Transplant; 2019 Nov; 38(11):1214-1223. PubMed ID: 31474491
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo lung graft perfusion.
Briot R; Gennai S; Maignan M; Souilamas R; Pison C
Anaesth Crit Care Pain Med; 2016 Apr; 35(2):123-31. PubMed ID: 26746565
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal/Stem Cells and Their Products as a Therapeutic Tool to Advance Lung Transplantation.
Miceli V; Bertani A
Cells; 2022 Feb; 11(5):. PubMed ID: 35269448
[TBL] [Abstract][Full Text] [Related]
13. [Lesion caused by ischemia-reperfusion in lung transplantation].
Soria A; Vicente R; Ramos F; López LM; Francia C; Montero R
Rev Esp Anestesiol Reanim; 2000 Nov; 47(9):380-5. PubMed ID: 11305137
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.
Mulloy DP; Stone ML; Crosby IK; Lapar DJ; Sharma AK; Webb DV; Lau CL; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1208-15. PubMed ID: 22944084
[TBL] [Abstract][Full Text] [Related]
15. Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors.
Dong B; Stewart PW; Egan TM
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):429-36.e1. PubMed ID: 23260460
[TBL] [Abstract][Full Text] [Related]
16. Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury.
Roesel MJ; Sharma NS; Schroeter A; Matsunaga T; Xiao Y; Zhou H; Tullius SG
Front Immunol; 2022; 13():891564. PubMed ID: 35686120
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death.
Stone ML; Zhao Y; Robert Smith J; Weiss ML; Kron IL; Laubach VE; Sharma AK
Respir Res; 2017 Dec; 18(1):212. PubMed ID: 29268735
[TBL] [Abstract][Full Text] [Related]
18. Ischemia-reperfusion-induced lung injury.
de Perrot M; Liu M; Waddell TK; Keshavjee S
Am J Respir Crit Care Med; 2003 Feb; 167(4):490-511. PubMed ID: 12588712
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.
Ibrahim M; Wang X; Puyo CA; Montecalvo A; Huang HJ; Hachem RR; Andreetti C; Menna C; Chen R; Krupnick AS; Kreisel D; Rendina EA; Gelman AE
J Heart Lung Transplant; 2015 Feb; 34(2):247-53. PubMed ID: 25455749
[TBL] [Abstract][Full Text] [Related]
20. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.
Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A
BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
